With a market capitalisation of ₹30,253 crores, CRISIL stands as a mid-cap leader in India's capital markets sector, backed by the credibility of S&P Global (66.64% promoter holding). The quarter's results reveal a company navigating the delicate balance between aggressive revenue growth and margin preservation, whilst facing valuation headwinds that have prompted analysts to adopt a cautious stance. The stock currently trades at a demanding 38x trailing twelve-month earnings, commanding a premium despite recent underperformance against both sectoral peers and broader market indices.
Quarterly Performance Trends: Growth with Growing Pains
| Quarter | Revenue (₹ Cr) | QoQ Change | Net Profit (₹ Cr) | QoQ Change | OPM % |
|---|---|---|---|---|---|
| Mar'26 | 1,057.66 | -2.21% | 233.26 | -3.41% | 30.12% |
| Dec'25 | 1,081.57 | +18.69% | 241.50 | +25.06% | 31.40% |
| Sep'25 | 911.24 | +8.09% | 193.10 | +12.55% | 28.89% |
| Jun'25 | 843.02 | +3.67% | 171.57 | +7.34% | 28.32% |
| Mar'25 | 813.18 | -10.92% | 159.84 | -28.86% | 28.53% |
| Dec'24 | 912.91 | +12.45% | 224.69 | +30.98% | 31.45% |
| Sep'24 | 811.84 | — | 171.55 | — | 27.57% |
Financial Performance: Revenue Momentum Meets Margin Headwinds
CRISIL's Q4 FY26 revenue performance demonstrates the company's ability to capitalise on India's expanding credit markets and research services demand. Net sales of ₹1,057.66 crores in the quarter represent a stellar 30.06% year-on-year expansion from ₹813.18 crores in Q4 FY25, though the sequential 2.21% decline from Q3 FY26's ₹1,081.57 crores suggests some seasonality and timing factors at play. The company's full-year revenue trajectory remains encouraging, with consistent double-digit growth across most quarters.
However, the margin picture presents a more nuanced narrative. Operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) stood at ₹318.57 crores in Q4 FY26, translating to an operating margin of 30.12%. Whilst this represents a healthy 159 basis points improvement over Q4 FY25's 28.53%, it marks a concerning 128 basis points sequential contraction from Q3 FY26's 31.40%. This margin compression stems primarily from elevated employee costs, which surged to ₹556.14 crores in Q4 FY26 from ₹427.09 crores in the year-ago quarter—a 30.22% year-on-year increase that outpaced revenue growth.
The company's net profit margin of 22.05% in Q4 FY26, whilst respectable, reflects the cumulative impact of rising operational costs and higher depreciation charges (₹39.42 crores versus ₹29.77 crores in Q4 FY25). Notably, the tax rate moderated to 24.36% in Q4 FY26 from 29.67% in the year-ago quarter, providing some cushion to bottom-line performance. Other income contributed ₹36.01 crores during the quarter, up from ₹30.59 crores in Q4 FY25, reflecting efficient treasury management of the company's substantial cash reserves.
Capital Efficiency: Exceptional Returns Despite Margin Pressures
Despite near-term margin challenges, CRISIL's capital efficiency metrics remain exemplary, underscoring the inherent quality of its asset-light business model. The company's average return on equity (ROE) of 28.60% positions it amongst the elite performers in India's capital markets sector, demonstrating management's ability to generate substantial returns from shareholder capital. This robust ROE reflects both strong profitability and efficient capital allocation, with the company maintaining a conservative balance sheet structure.
Even more impressive is CRISIL's average return on capital employed (ROCE) of 52.83%, a metric that highlights the exceptional returns generated from the company's operational assets. This extraordinary ROCE stems from the company's minimal fixed asset requirements and negative working capital cycle—characteristics typical of high-quality knowledge-based businesses. The latest ROCE figure of 40.73%, whilst lower than the five-year average, remains substantially above most corporate benchmarks and validates the company's pricing power and operational excellence.
CRISIL's balance sheet strength provides additional comfort. The company operates as a net cash entity with a negative net debt-to-equity ratio of -0.24, meaning cash and investments exceed total debt. As of December 2025, shareholder funds stood at ₹3,033.44 crores, with zero long-term debt and current assets of ₹2,269.65 crores comfortably covering current liabilities of ₹1,206.30 crores. This fortress balance sheet affords management significant strategic flexibility for investments, acquisitions, or enhanced shareholder returns.
Exceptional Capital Efficiency
CRISIL's average ROE of 28.60% and ROCE of 52.83% place it amongst India's most capital-efficient businesses. The asset-light model, combined with strong pricing power and minimal debt, enables the company to generate exceptional returns whilst maintaining financial flexibility for growth initiatives and consistent dividend distributions.
Employee Cost Dynamics: Talent Retention in a Competitive Market
The most significant pressure point in CRISIL's Q4 FY26 results emanates from employee costs, which have emerged as the primary margin headwind. Employee expenses of ₹556.14 crores in Q4 FY26 represent 52.59% of revenue, up from 52.51% in the year-ago quarter. This 30.22% year-on-year increase in absolute employee costs reflects the intense competition for analytical and research talent in India's expanding financial services ecosystem.
The elevated employee cost trajectory appears structural rather than temporary, driven by several factors: aggressive hiring to support business expansion, annual salary increments, performance bonuses, and competitive pressures from consulting firms, investment banks, and fintech companies vying for similar talent pools. Whilst these investments in human capital are essential for maintaining service quality and supporting growth, they present near-term margin challenges that management must navigate carefully.
Looking at the annual trend, employee costs grew from ₹1,068 crores in FY2020 to ₹1,765 crores in FY2024, representing a compound annual growth rate of approximately 13.4%—marginally above the revenue CAGR of 12.99% over the same period. This suggests that whilst CRISIL has managed to maintain reasonable operating leverage, the company faces ongoing pressure to balance talent investments with profitability objectives.
Margin Pressure from Talent Costs
Employee costs of ₹556.14 crores in Q4 FY26 grew 30.22% year-on-year, outpacing revenue growth and compressing operating margins by 128 basis points sequentially. The competitive talent market in financial services requires careful monitoring, as sustained cost inflation without commensurate pricing power could threaten the company's historically strong profitability profile.
Peer Comparison: Premium Valuation Amid Sector Leadership
| Company | P/E (TTM) | P/BV | ROE % | Div Yield % | Debt/Equity |
|---|---|---|---|---|---|
| CRISIL | 37.84 | 10.47 | 28.60 | 1.40 | -0.24 |
| Nippon Life India | 44.99 | 14.81 | 26.06 | 1.86 | 0.02 |
| Motilal Oswal Financial | 24.21 | 3.81 | 22.76 | 0.74 | 1.22 |
| 360 ONE | 38.28 | 4.82 | 19.24 | 1.06 | 1.47 |
| Anand Rathi Wealth | 77.72 | 30.82 | 38.69 | 0.16 | 0.08 |
| Aditya Birla AMC | 30.40 | 8.68 | 26.55 | 2.24 | 0.02 |
CRISIL's positioning within the capital markets peer group reveals a company commanding premium valuations justified by superior operational metrics but facing questions about growth sustainability. The company's trailing P/E ratio of 37.84x sits comfortably below Nippon Life India's 44.99x and Anand Rathi Wealth's stratospheric 77.72x, yet significantly above Motilal Oswal Financial's 24.21x and Aditya Birla AMC's 30.40x. This mid-tier valuation positioning reflects market recognition of CRISIL's quality franchise whilst acknowledging concerns about near-term growth deceleration.
More tellingly, CRISIL's ROE of 28.60% stands as the second-highest in the peer group after Anand Rathi Wealth's 38.69%, validating the premium valuation to some extent. The company's price-to-book ratio of 10.47x appears reasonable compared to Nippon Life India's 14.81x and Anand Rathi Wealth's 30.82x, though substantially higher than Motilal Oswal's 3.81x—a reflection of differing business models and growth trajectories. CRISIL's net cash position (negative debt-to-equity of -0.24) provides additional quality differentiation versus leveraged peers.
The dividend yield comparison reveals CRISIL's 1.40% yield positioned mid-pack, trailing Aditya Birla AMC's attractive 2.24% and Nippon Life India's 1.86%, but ahead of most other peers. With a dividend payout ratio of 59.84%, CRISIL demonstrates commitment to shareholder returns whilst retaining sufficient capital for growth investments—a balanced approach that appeals to income-oriented investors without compromising reinvestment capacity.
Valuation Analysis: Premium Pricing for Quality, but Limited Upside
CRISIL's current valuation presents a conundrum for investors: undeniable business quality and market leadership offset by demanding multiples that leave limited room for error. Trading at 37.84x trailing earnings, the stock commands a premium to the capital markets sector average P/E of 36x, despite recent underperformance. The price-to-book ratio of 10.47x, whilst lower than some wealth management peers, remains elevated by historical standards and reflects market expectations for sustained high returns on equity.
The PEG ratio of 2.01 emerges as a critical concern, suggesting the stock trades at twice its growth rate—a level typically associated with overvaluation. With five-year sales growth of 12.99% and EBIT growth of 20.10%, CRISIL's growth profile, whilst respectable, doesn't justify the current valuation premium according to traditional metrics. The EV/EBITDA multiple of 26.77x and EV/EBIT of 30.39x further underscore the premium pricing, leaving the stock vulnerable to multiple compression if growth disappoints or margins deteriorate further.
The stock's 31.51% decline from its 52-week high of ₹6,329.95 reflects market recalibration of growth expectations and valuation normalisation. Currently trading 11.34% above the 52-week low of ₹3,893.85, CRISIL occupies an uncomfortable middle ground—neither cheap enough to attract value investors nor exhibiting sufficient growth momentum to justify growth-oriented allocations. The company's fair value estimate, based on peer comparisons and DCF analysis, suggests limited upside from current levels, with downside risks if margin pressures persist.
Shareholding Pattern: Stable Promoter Base, Marginal Institutional Shifts
| Shareholder Category | Dec'25 | Sep'25 | Jun'25 | QoQ Change |
|---|---|---|---|---|
| Promoter Holdings | 66.64% | 66.64% | 66.64% | 0.00% |
| FII Holdings | 7.67% | 7.82% | 8.07% | -0.15% |
| Mutual Fund Holdings | 6.55% | 6.85% | 6.63% | -0.30% |
| Insurance Holdings | 5.14% | 4.80% | 4.98% | +0.34% |
| Other DII Holdings | 0.41% | 0.53% | 0.45% | -0.12% |
| Non-Institutional | 13.59% | 13.37% | 13.22% | +0.22% |
CRISIL's shareholding pattern reflects a stable ownership structure anchored by S&P Global's unwavering 66.64% promoter stake, providing strategic continuity and access to global best practices. The promoter holding, split between S&P India LLC (42.68%), S&P Asian Holdings Pte. Ltd. (15.76%), and Standard & Poor's International LLC (8.20%), has remained unchanged for multiple quarters, signalling long-term commitment from the global parent.
The institutional shareholding dynamics reveal subtle but noteworthy shifts. Foreign institutional investors reduced their stake marginally to 7.67% in Q3 FY26 from 7.82% in Q2 FY26, continuing a gradual trimming trend from 8.07% in Q1 FY26. Similarly, mutual fund holdings declined to 6.55% from 6.85% quarter-on-quarter, suggesting some profit-booking by domestic institutional investors following the stock's recent volatility. These modest reductions, whilst not alarming, indicate tempered institutional enthusiasm at current valuations.
Conversely, insurance companies increased their holdings to 5.14% from 4.80%, representing the sole category of institutional buying during the quarter. This 34 basis point increase suggests that longer-term institutional investors see value in CRISIL's defensive characteristics and dividend profile. The non-institutional shareholding edged up to 13.59% from 13.37%, indicating retail investor interest remains intact despite the stock's underwhelming performance over the past year.
Stock Performance: Underperformance Across Timeframes Raises Concerns
| Period | CRISIL Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +5.73% | +1.22% | +4.51% |
| 1 Month | +8.12% | +3.18% | +4.94% |
| 3 Months | -8.54% | -6.07% | -2.47% |
| 6 Months | -8.03% | -6.50% | -1.53% |
| Year-to-Date | +0.23% | -7.89% | +8.12% |
| 1 Year | -4.69% | -0.08% | -4.61% |
| 2 Years | -7.40% | +7.61% | -15.01% |
| 3 Years | +22.83% | +31.02% | -8.19% |
| 5 Years | +131.49% | +60.74% | +70.75% |
CRISIL's stock performance paints a picture of recent struggles despite long-term wealth creation. The immediate post-results rally of 5.36% and strong one-week gain of 5.73% demonstrate market relief at the top-line growth, but this short-term strength masks concerning medium-term underperformance. The stock has delivered negative alpha across most meaningful timeframes, underperforming the Sensex by 4.61% over one year, 15.01% over two years, and 8.19% over three years.
The three-month and six-month returns of -8.54% and -8.03% respectively highlight the stock's vulnerability during the recent market correction, with CRISIL declining more than the Sensex's -6.07% and -6.50% over the same periods. This higher beta characteristic (1.20) manifests during downturns, with the stock exhibiting greater volatility than the broader market. The 30.12% volatility classification places CRISIL in the "medium risk, medium return" category, though recent returns have skewed towards higher risk without commensurate rewards.
The five-year perspective offers more comfort, with CRISIL delivering 131.49% returns against the Sensex's 60.74%—a substantial 70.75% alpha generation that reflects the company's fundamental quality and growth during the 2021-2026 period. However, this long-term outperformance increasingly appears in the rear-view mirror, with the stock's momentum clearly waning over the past two years as valuation concerns and growth moderation have taken centre stage.
Investment Thesis: Quality Franchise Confronts Valuation Reality
CRISIL's investment proposition rests on several enduring strengths: market-leading position in credit ratings and research, asset-light business model generating exceptional returns on capital, fortress balance sheet with net cash position, S&P Global backing providing strategic advantages, and consistent dividend payments supported by strong cash generation. These qualities have historically justified premium valuations and attracted long-term institutional investors seeking defensive exposure to India's financial services ecosystem.
However, the current valuation framework presents significant challenges. The proprietary Mojo Score of 42/100 and "SELL" rating reflect a confluence of concerns: PEG ratio of 2.01 indicating expensive valuation relative to growth, mildly bearish technical trend suggesting momentum weakness, consistent underperformance against benchmarks over multiple timeframes, and margin pressures from rising employee costs threatening profitability sustainability. These factors collectively argue for caution despite the company's undeniable quality credentials.
The valuation grade of "Very Expensive" has persisted since late 2022, with brief interludes of "Expensive" classification, suggesting the market has consistently priced in optimistic growth assumptions. The quality grade of "Good" (downgraded from "Excellent" in January 2026) and positive financial trend provide some comfort, but these positives appear fully reflected in current prices. The technical trend classification of "Mildly Bearish" adds another layer of concern, with the stock trading below all major moving averages and facing resistance at multiple levels.
Key Strengths & Risk Factors
KEY STRENGTHS
- Market leadership in credit ratings with strong brand equity and regulatory moat
- Exceptional capital efficiency with 28.60% ROE and 52.83% average ROCE
- Net cash balance sheet (debt-to-equity of -0.24) providing strategic flexibility
- S&P Global promoter holding (66.64%) ensures global best practices and strategic support
- Asset-light business model with minimal capex requirements and negative working capital
- Consistent dividend payer with 59.84% payout ratio balancing returns and reinvestment
- Strong revenue growth of 30.06% YoY in Q4 FY26 demonstrates market share gains
KEY CONCERNS
- Premium valuation with P/E of 37.84x and PEG ratio of 2.01x limiting upside potential
- Sequential margin compression of 128 bps QoQ raises sustainability concerns
- Employee cost inflation (30.22% YoY) outpacing revenue growth pressures profitability
- Consistent underperformance vs. Sensex across 1-year (-4.61%), 2-year (-15.01%), and 3-year (-8.19%) periods
- High beta of 1.20 amplifies downside during market corrections
- Quality grade downgrade from "Excellent" to "Good" signals deteriorating fundamentals
- Mildly bearish technical trend with stock below all major moving averages
Outlook: What to Watch in Coming Quarters
POSITIVE CATALYSTS
- Margin stabilisation or improvement through operational efficiencies and pricing power
- Sustained revenue growth above 15% driven by expanding credit markets and research services
- Market share gains in analytics and risk solutions segments
- Strategic acquisitions leveraging strong balance sheet to accelerate growth
- Valuation normalisation creating attractive entry points for long-term investors
RED FLAGS TO MONITOR
- Further margin compression below 28-29% operating margin range
- Employee cost ratios exceeding 55% of revenue on sustained basis
- Sequential revenue decline for two consecutive quarters signalling demand weakness
- Increased competitive intensity from new entrants or pricing pressures
- Technical breakdown below ₹3,893 (52-week low) triggering further selling pressure
The coming quarters will prove critical in determining whether CRISIL can navigate the delicate balance between growth investments and margin preservation. Management commentary on employee cost trends, pricing strategies, and margin outlook will be closely scrutinised. The company's ability to sustain double-digit revenue growth whilst stabilising operating margins around 30-31% will largely determine whether the current valuation premium remains justified or faces further compression.
The Verdict: Quality Franchise, but Price Matters
Score: 42/100
For Fresh Investors: Avoid initiating positions at current valuations. Whilst CRISIL remains a high-quality franchise with strong fundamentals, the demanding P/E of 37.84x and PEG ratio of 2.01x leave limited margin of safety. Consider building positions only on significant corrections towards ₹3,600-3,800 levels, representing 15-20% downside from current prices, where risk-reward becomes more favourable.
For Existing Holders: Consider reducing exposure on rallies towards ₹4,500-4,600 levels to book partial profits. The combination of premium valuation, margin pressures, and consistent underperformance suggests better risk-adjusted opportunities exist elsewhere. Long-term holders with conviction in the business model may maintain core positions but should avoid averaging up at current prices.
Fair Value Estimate: ₹3,700-3,900 (15-18% downside from current levels) based on 30-32x forward earnings and peer comparison analysis.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance does not guarantee future results, and all investments carry inherent risks including potential loss of principal.
